Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-04-21
1998-07-07
Jarvis, William R. A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
A61K 3155
Patent
active
057769281
ABSTRACT:
The invention provides a method for treating a dyskinesias comprising administering an effective amount of
REFERENCES:
patent: 5229382 (1993-07-01), Chakrabarti et al.
Moore et al, Chemical Abstracts, vol. 117, No. 19, abstract No. 184704w, 1992, p. 70.
Gerlach, et al., "Intolerance to neuroleptic drugs: the art of avoiding extrapyramidal syndromes", European Psychiatry, 10:1 (1994).
Moore, et al., "The behavioral pharmacology of olanzapine, a novel Atypical Antipsychotic Agent", J. Pharm. Exp. Ther., 262:2 pp. 545-551 (1992).
Tamminga, et al., "Clozapine in tardive dyskinesia: observations from human and animal model studies" J. Clin. Psychiatry, 55:9, pp. 102-106 (1994).
Boone David E.
Eli Lilly and Company
Jarvis William R. A.
Vorndran-Jones MaCharri
LandOfFree
Method for treating dyskinesias with olanzapine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating dyskinesias with olanzapine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating dyskinesias with olanzapine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1206093